Feedback / Questions
BEN-8744 - BenevolentAI
https://www.businesswire.com/news/home/20221220005769/en/BenevolentAI-submits-CTA-for-BEN-8744-an-oral-PDE10-inhibitor-as-a-first-in-class-treatment-for-ulcerative-colitis
Dec 21, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next